Vuori J, Rasi S, Takala T, Väänänen K
Deaconess Institute of Oulu, Finland.
Clin Chem. 1991 Dec;37(12):2087-92.
We developed a dual-labeled time-resolved fluoroimmunoassay for simultaneous quantification of myoglobin (Mb) and carbonic anhydrase III (CA III) in serum involving polyclonal antibodies and the fluorescent lanthanides europium (Eu3+) and samarium (Sm3+). This solid-phase immunoassay is based on competition between Eu(3+)- or Sm(3+)-labeled antigen and the sample antigen for polyclonal rabbit antibodies. Standards and patients' samples containing antigen inhibit binding of the lanthanide-labeled antigen to the antibody. A second antibody directed against rabbit IgG is coated on a solid phase and binds the IgG-antigen-lanthanide complex, giving rapid and complete separation of antibody-bound and free antigen. The assay requires only one incubation step. An enhancement solution dissociates Eu3+ and Sm3+ ions from the labeled CA III and Mb, respectively, into a solution where they form highly fluorescent chelates. Spectra of the fluorescent chelates in the microtitration-strip wells were run on a time-resolved fluorometer equipped with filters for Eu3+ (613 nm) and Sm3+ (643 nm), the fluorescence from each sample being inversely proportional to the concentration of antigens. The measurement range for both analytes is from 5 to 1500 micrograms/L. The mean within- and between-assay precisions (CV) were 4.6% and 6.2% for CA III and 5.9% and 7.3% for Mb, respectively. Good correlations were obtained with the results of CA III RIA and a commercial myoglobin RIA kit.
我们开发了一种双标记时间分辨荧光免疫测定法,用于同时定量血清中的肌红蛋白(Mb)和碳酸酐酶III(CA III),该方法涉及多克隆抗体以及荧光镧系元素铕(Eu3+)和钐(Sm3+)。这种固相免疫测定法基于Eu(3+)或Sm(3+)标记的抗原与样品抗原竞争兔多克隆抗体。含有抗原的标准品和患者样品会抑制镧系元素标记的抗原与抗体的结合。一种针对兔IgG的二抗包被在固相上,并结合IgG - 抗原 - 镧系元素复合物,从而快速、完全地分离抗体结合的抗原和游离抗原。该测定仅需一个孵育步骤。增强溶液分别将Eu3+和Sm3+离子从标记的CA III和Mb中解离到溶液中,在那里它们形成高荧光螯合物。在配备有Eu3+(613 nm)和Sm3+(643 nm)滤光片的时间分辨荧光计上读取微量滴定板孔中荧光螯合物的光谱,每个样品的荧光与抗原浓度成反比。两种分析物的测量范围均为5至1500微克/升。CA III的批内和批间精密度均值(CV)分别为4.6%和6.2%,Mb的批内和批间精密度均值(CV)分别为5.9%和7.3%。与CA III放射免疫分析结果和商用肌红蛋白放射免疫分析试剂盒的结果具有良好的相关性。